ANDA 71188, held by Abraxis Pharm. Ritodrine Hydrochloride.
As of Nov 16, 2026, ANDA 71188 (Ritodrine Hydrochloride), held by Abraxis Pharm, was first approved by FDA on Jul 23, 1987, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 23, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ritodrine Hydrochloride10MG/ML ยท injectable;injection | Ritodrine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters